Monday, October 3, 2016

Surgical Spirit BP





1. Name Of The Medicinal Product



Surgical Spirit BP.


2. Qualitative And Quantitative Composition



Virgin Castor Oil 2.5% v/v



Methyl Salicylate 0.5% v/v



For full list of excipients see section 6.1



3. Pharmaceutical Form



Cutaneous Solution.



4. Clinical Particulars



4.1 Therapeutic Indications



To prevent bed sores and for hardening the skin of the feet.



4.2 Posology And Method Of Administration



Topical application.



Applied directly to the skin.



Recommended Dose and Dosage Schedule



The product is suitable for use by adults, children and the elderly. To be used as required.



4.3 Contraindications



None known.



4.4 Special Warnings And Precautions For Use



For external use only.



Keep all medicines away from children.



Do not apply to broken skin.



Caution: this preparation is flammable, keep away from a naked flame.



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



None known.



4.6 Pregnancy And Lactation



No evidence is available as to the safety of the product when used during pregnancy and lactation. In such cases therefore use with caution.



4.7 Effects On Ability To Drive And Use Machines



None known.



4.8 Undesirable Effects



None known.



4.9 Overdose



This product is recommended for external use only and as such overdose is unlikely, although methyl alcohol is absorbed through the skin and may produce systemic effects.



If taken internally the immediate symptoms will be those of alcohol intoxication followed by characteristic symptoms after a latent period of up to 48 hours (usually 12-18 hours). The symptoms of methanol poisoning include severe abdominal pain, metabolic acidosis with rapid, shallow breathing and visual disturbances which may proceed to irreversible blindness. Other symptoms include headache, nausea, vomiting, diarrhoea, weakness, vertigo, ataxia, mild tachycardia, confusion, dizziness, delirium and coma which in severe cases may terminate in death due to respiratory failure or rarely in circulatory collapse.



Recent ingestion should be treated by gastric lavage with sodium bicarbonate solution 2-5%, together with treatment for shock and respiratory failure. Acidosis should be corrected with intravenous sodium bicarbonate or compound sodium lactate. Delirium if it occurs may be treated with diazepam. In severe cases haemodialysis may be effective.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Castor oil is used as an emollient.



Methyl salicylate has the action of salicylates, causing dilation of the skin vessels also.



5.2 Pharmacokinetic Properties



Methyl salicylate is absorbed through the skin.



5.3 Preclinical Safety Data



None.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Industrial Methylated Spirit 660P (95%)



Diethyl Phthalate



6.2 Incompatibilities



None known.



6.3 Shelf Life



36 months.



6.4 Special Precautions For Storage



Do not store above 25°C.



Flammable: Keep away from a naked flame.



6.5 Nature And Contents Of Container












100ml




Glass bottle with plastic cap or polypropylene child-resistant cap with saranex faced EPE liner or white 28mm cap with tamper evident band and EPE saranex liner




200ml




Glass bottle with plastic cap or polypropylene child-resistant cap with saranex faced EPE liner or white 28mm cap with tamper evident band and EPE saranex liner




500ml




Amber glass bottle with polypropylene cap or polypropylene child-resistant cap with saranex faced EPE liner or white 20mm cap with tamper evident band and EPE saranex liner




2000ml




Polythene bottle with cap



6.6 Special Precautions For Disposal And Other Handling



None.



7. Marketing Authorisation Holder



L. C. M. Ltd.



Linthwaite Laboratories



Huddersfield



HD7 5QH.



8. Marketing Authorisation Number(S)



PL: 12965/0035



9. Date Of First Authorisation/Renewal Of The Authorisation



25.08.93 / 10.12.98



10. Date Of Revision Of The Text



5th October 2009



11 DOSIMETRY (IF APPLICABLE)


Not Applicable



12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS (IF APPLICABLE)


Not Applicable




No comments:

Post a Comment